RESUMO
Tropical forests cover 7% of the earth's surface and hold 50% of known terrestrial arthropod species. Alarming insect declines resulting from human activities have recently been documented in temperate and tropical ecosystems worldwide, but reliable data from tropical forests remain sparse. The sap-sucking tribe Athysanini is one herbivore group sensitive to anthropogenic perturbation and the largest within the diverse insect family Cicadellidae distributed in America's tropical forests. To measure the possible effects of deforestation and related activities on leafhopper biodiversity, a survey of 143 historic collecting localities was conducted to determine whether species documented in the Mexican dry tropical forests during the 1920s to 1940s were still present. Biostatistical diversity analysis was performed to compare historical to recent data on species occurrences. A data matrix of 577 geographical records was analysed. In total, 374 Athysanini data records were included representing 115 species of 41 genera. Historically, species richness and diversity were higher than found in the recent survey, despite greater collecting effort in the latter. A strong trend in species decline was observed (-53%) over 75 years in this endangered seasonally dry ecosystem. Species completeness was dissimilar between historic and present data. Endemic taxa were significantly less important and represented in the 1920s-1940s species records. All localities surveyed in the dry tropical forest are disturbed and reduced by modern anthropogenic processes. Mexico harbours highly endemic leafhopper taxa with a large proportion of these inhabiting the dry forest. These findings provide important data for conservation decision making and modelling of distribution patterns of this threatened seasonally dry tropical ecosystem.
RESUMO
ABSTRACT Two nomenclatural changes are proposed in the tribe Athysanini (Cicadellidae: Deltocephalinae). Chlorotettix sexvarus DeLong, 1959, is newly placed in the genus Cocrassana Blocker & Larsen and is a senior synonym of the type species of Cocrassana, C. riepmai Blocker & Larsen, 1991, syn. nov. A revised diagnosis and illustration of the species are provided.
RESUMO
Ceratagallia (Ceratagallia) brailovskyi sp. nov., is here described and illustrated from Central Mexico. The new species appears to be closely related to the C. bigeloviae species group, which includes previously described Mexican species. A key, species list, and distributional map for Ceratagallia in Mexico are provided.
Assuntos
Hemípteros , Animais , China , MéxicoRESUMO
The new leafhopper genus, Duocrassana Pinedo-Escatel, Zahniser & Dietrich, gen. nov., and its type species, Duocrassana longula Pinedo-Escatel, Zahniser & Dietrich sp. nov., are described and illustrated based on material from Oaxaca, Mexico. The relationship with other genera in the tribe Athysanini is discussed, highlighting the importance of male genitalia for its identification.
Assuntos
Hemípteros/anatomia & histologia , Hemípteros/classificação , Animais , Feminino , Masculino , México , Especificidade da EspécieRESUMO
PURPOSE: Short-term outcomes have been well characterized in acute coronary syndromes; however,longer-term follow-up for the entire spectrum of these patients, including ST-segment-elevation myocardialinfarction, non-ST-segment-elevation myocardial infarction, and unstable angina, is more limited. Therefore,we describe the longer-term outcomes, procedures, and medication use in Global Registry of AcuteCoronary Events (GRACE) hospital survivors undergoing 6-month and 2-year follow-up, and the performanceof the discharge GRACE risk score in predicting 2-year mortality.METHODS: Between 1999 and 2007, 70,395 patients with a suspected acute coronary syndrome wereenrolled. In 2004, 2-year prospective follow-up was undertaken in those with a discharge acute coronarysyndrome diagnosis in 57 sites.RESULTS: From 2004 to 2007, 19,122 (87.2%) patients underwent follow-up; by 2 years postdischarge,14.3% underwent angiography, 8.7% percutaneous coronary intervention, 2.0% coronary bypass surgery,and 24.2% were re-hospitalized. In patients with 2-year follow-up, acetylsalicylic acid (88.7%), betablocker(80.4%), renin-angiotensin system inhibitor (69.8%), and statin (80.2%) therapy was used. Heartfailure occurred in 6.3%, (re)infarction in 4.4%, and death in 7.1%. Discharge-to-6-month GRACE riskscore was highly predictive of all-cause mortality at 2 years (c-statistic 0.80).CONCLUSION: In this large multinational cohort of acute coronary syndrome patients, there were importantlater adverse consequences, including frequent morbidity and mortality. These findings were seen in thecontext of additional coronary procedures and despite continued use of evidence-based therapies in a highproportion of patients. The discriminative accuracy of the GRACE risk score in hospital survivors forpredicting longer-term mortality was maintained.
Assuntos
Infarto do Miocárdio , Revascularização Miocárdica , Síndrome Coronariana AgudaRESUMO
PURPOSE: Short-term outcomes have been well characterized in acute coronary syndromes; however,longer-term follow-up for the entire spectrum of these patients, including ST-segment-elevation myocardialinfarction, non-ST-segment-elevation myocardial infarction, and unstable angina, is more limited. Therefore,we describe the longer-term outcomes, procedures, and medication use in Global Registry of AcuteCoronary Events (GRACE) hospital survivors undergoing 6-month and 2-year follow-up, and the performanceof the discharge GRACE risk score in predicting 2-year mortality.METHODS: Between 1999 and 2007, 70,395 patients with a suspected acute coronary syndrome wereenrolled. In 2004, 2-year prospective follow-up was undertaken in those with a discharge acute coronarysyndrome diagnosis in 57 sites.RESULTS: From 2004 to 2007, 19,122 (87.2%) patients underwent follow-up; by 2 years postdischarge,14.3% underwent angiography, 8.7% percutaneous coronary intervention, 2.0% coronary bypass surgery,and 24.2% were re-hospitalized. In patients with 2-year follow-up, acetylsalicylic acid (88.7%), betablocker(80.4%), renin-angiotensin system inhibitor (69.8%), and statin (80.2%) therapy was used. Heartfailure occurred in 6.3%, (re)infarction in 4.4%, and death in 7.1%. Discharge-to-6-month GRACE riskscore was highly predictive of all-cause mortality at 2 years (c-statistic 0.80).CONCLUSION: In this large multinational cohort of acute coronary syndrome patients, there were importantlater adverse consequences, including frequent morbidity and mortality. These findings were seen in thecontext of additional coronary procedures and despite continued use of evidence-based therapies in a highproportion of patients. The discriminative accuracy of the GRACE risk score in hospital survivors forpredicting longer-term mortality was maintained.
Assuntos
Infarto do Miocárdio , Revascularização Miocárdica , Síndrome Coronariana AgudaRESUMO
The EC rabbit endothelial cell line was transfected with the EJ-ras oncogene (EJ-ras EC). EJ-ras EC cells display over expression of the Ras oncogene, morphological changes and deregulation of the cell cycle, becoming more densely populated and serum-independent. In addition, EJ-ras-transfectant cells show higher levels of the syndecan-4 mRNA. In addition to the increase in the core protein, a parallel increase in the glycosylation of the syndecan-4 protein, a proteoglycan that bears heparan sulfate chains, also occurs. This increase is observed both for the heparan sulfate proteoglycan synthesized by the cells and for that secreted to the culture medium. This enhancement in heparan sulfate synthesis was observed through metabolic labeling of the cells, immunoprecipitation of syndecan-4 and heparitinases treatment. Furthermore, the EJ-ras-transfectant cells do not exhibit decreased synthesis of heparan sulfate during the G(1)-S phase transition, as observed for the parental cell line. Also, heparan sulfate synthesis is not stimulated by PMA as displayed by parental endothelial cells. Significant structural changes of heparan sulfate, such as decreased O-sulfation, were observed in the EJ-ras-transfected cells. Decreases in the mRNA levels of some enzymes (glucuronosyl C-5 epimerase, iduronosyl-2-O-sulfotransferase, glucosaminyl-6-O-sulfotransferase-1 and N-deacetylase/N-sulfotransferase-1), involved in the biosynthetic pathway of heparan sulfate, were also observed. The results suggest that overexpression of the EJ-ras oncogene alters the cell cycle, through signal transduction cascades, upregulates the expression of syndecan-4, and downregulates enzymes involved in the heparan sulfate biosynthesis related to chain modification, leading to the structural changes of the heparan sulfate syndecan-4 proteoglycan in endothelial cells.
Assuntos
Carboidratos Epimerases/metabolismo , Células Endoteliais/metabolismo , Proteínas Oncogênicas/metabolismo , Sulfotransferases/metabolismo , Sindecana-4/metabolismo , Animais , Bromodesoxiuridina/metabolismo , Carboidratos Epimerases/genética , Regulação para Baixo , Células Endoteliais/enzimologia , Citometria de Fluxo , Fase G1 , Proteoglicanas de Heparan Sulfato/biossíntese , Humanos , Coelhos , Fase S , Transdução de Sinais , Sulfotransferases/genética , Sindecana-4/genética , Transfecção , Regulação para CimaRESUMO
The syndecans, heparan sulfate proteoglycans, are abundant molecules associated with the cell surface and extracellular matrix and consist of a protein core to which heparan sulfate chains are covalently attached. Each of the syndecan core proteins has a short cytoplasmic domain that binds cytosolic regulatory factors. The syndecans also contain highly conserved transmembrane domains and extracellular domains for which important activities are becoming known. These protein domains locate the syndecan on cell surface sites during development and tumor formation where they interact with other receptors to regulate signaling and cytoskeletal organization. The functions of cell surface heparan sulfate proteoglycan have been centered on the role of heparan sulfate chains, located on the outer side of the cell surface, in the binding of a wide array of ligands, including extracellular matrix proteins and soluble growth factors. More recently, the core proteins of the syndecan family transmembrane proteoglycans have also been shown to be involved in cell signaling through interaction with integrins and tyrosine kinase receptors.